FATN vs. ERNA
FATN (FatPipe, Inc) and ERNA (Eterna Therapeutics Inc) are both stocks. FATN operates in Software - Infrastructure (Technology), while ERNA operates in Biotechnology (Healthcare). Over the past year, FATN returned -38.43% vs -87.57% for ERNA. At a 0.05 correlation, their price movements are largely independent.
Performance
FATN vs. ERNA - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, FATN achieves a 164.85% return, which is significantly higher than ERNA's -79.80% return.
FATN
- 1D
- -0.19%
- 1M
- -11.57%
- 6M
- 152.36%
- YTD
- 164.85%
- 1Y
- -38.43%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
ERNA
- 1D
- 2.19%
- 1M
- -1.46%
- 6M
- -81.50%
- YTD
- -79.80%
- 1Y
- -87.57%
- 3Y*
- -81.25%
- 5Y*
- -85.57%
- 10Y*
- -62.07%
FATN vs. ERNA - Yearly Performance Comparison
| 2026 (YTD) | 2025 | |
|---|---|---|
FATN FatPipe, Inc | 164.85% | -68.92% |
ERNA Eterna Therapeutics Inc | -79.80% | -57.08% |
Correlation
The correlation between FATN and ERNA is 0.06, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.06 |
Correlation (All Time) Calculated using the full available price history since Apr 8, 2025 | 0.05 |
Fundamentals
FATN:
$75.04M
ERNA:
$1.90M
FATN:
$0.08
ERNA:
-$23.80
FATN:
$15.13M
ERNA:
$0.00
FATN:
$13.71M
ERNA:
-$69.00K
FATN:
$2.19M
ERNA:
-$11.25M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
FATN vs. ERNA — Risk / Return Rank
FATN
ERNA
FATN vs. ERNA - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for FatPipe, Inc (FATN) and Eterna Therapeutics Inc (ERNA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| FATN | ERNA | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.29 | ||
| Sortino ratioReturn per unit of downside risk | +1.69 | ||
| Omega ratioGain probability vs. loss probability | 1.06 | 0.87 | +0.20 |
| Calmar ratioReturn relative to maximum drawdown | -0.51 | -0.94 | +0.43 |
| Martin ratioReturn relative to average drawdown | -0.72 | -1.38 | +0.65 |
Loading charts...
Drawdowns
FATN vs. ERNA - Drawdown Comparison
The maximum FATN drawdown since its inception was -88.85%, smaller than the maximum ERNA drawdown of -100.00%. Use the drawdown chart below to compare losses from any high point for FATN and ERNA.
Loading charts...
Drawdown Indicators
| FATN | ERNA | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -88.85% | -100.00% | +11.15% |
Max Drawdown (1Y)Largest decline over 1 year | -83.69% | -93.32% | +9.63% |
Max Drawdown (3Y)Largest decline over 3 years | — | -99.67% | — |
Max Drawdown (5Y)Largest decline over 5 years | — | -100.00% | — |
Max Drawdown (10Y)Largest decline over 10 years | — | -100.00% | — |
Current DrawdownCurrent decline from peak | -58.85% | -100.00% | +41.15% |
Average DrawdownAverage peak-to-trough decline | -60.73% | -86.18% | +25.45% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 60.18% | 63.64% | -3.46% |
Volatility
FATN vs. ERNA - Volatility Comparison
The current volatility for FatPipe, Inc (FATN) is 23.13%, while Eterna Therapeutics Inc (ERNA) has a volatility of 26.61%. This indicates that FATN experiences smaller price fluctuations and is considered to be less risky than ERNA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| FATN | ERNA | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 23.13% | 26.61% | -3.48% |
Volatility (6M)Calculated over the trailing 6-month period | 114.25% | 130.04% | -15.79% |
Volatility (1Y)Calculated over the trailing 1-year period | 149.13% | 151.77% | -2.64% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 180.96% | 114.08% | +66.88% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 180.96% | 149.04% | +31.92% |
Dividends
FATN vs. ERNA - Dividend Comparison
Neither FATN nor ERNA has paid dividends to shareholders.
Financials
FATN vs. ERNA - Financials Comparison
This section allows you to compare key financial metrics between FatPipe, Inc and Eterna Therapeutics Inc. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
FATN and ERNA have a correlation of 0.06, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
ERNA has higher volatility (26.61%) compared to FATN (23.13%). In terms of maximum drawdown, FATN dropped -88.85% vs ERNA's -100.00%.
FATN currently has the higher Sharpe Ratio (-0.29 vs -0.58), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for FATN and ERNA
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer